Scientists use AI to create new antibiotics that can kill deadly drug-resistant superbugs
How researchers developed drugs to fight antimicrobial resistance
- Researchers at the Massachusetts Institute of Technology (MIT) have utilised artificial intelligence to develop two new antibiotics.
- These drugs, named NG1 and DN1, have shown effectiveness against drug-resistant strains of gonorrhoea and MRSA in lab and animal tests.
- The new compounds attack bacterial membranes in novel ways, offering hope that bacteria will find it harder to develop resistance compared to existing medicines.
- This breakthrough addresses the growing global public health crisis of antimicrobial resistance, which is responsible for over one million deaths annually.
- The antibiotics are currently in early development and require extensive testing, including clinical trials, to prove their safety and efficacy in humans.